Rationale Evidence links longevity to dietary restriction (DR). A decrease in body temperature (T b ) is thought to contribute to enhanced longevity because lower T b reduces oxidative metabolism and oxidative stress. It is as yet unclear how DR decreases T b .
Introduction
Dietary restriction (DR), defined by a decrease in food intake, lowers core body temperature, enhances longevity, and attenuates progression of neurodegenerative diseases in animal models (Contestabile 2009 ). These effects have been suggested to be through a reduction in metabolic demand associated with a decrease in body temperature (T b ; Ungvari et al. 2008) . A recent study found that increasing temperature of the hypothalamus in mice decreased core T b and increased life span (Conti et al. 2006 ). However, a mechanistic link between metabolism or nutrient homeostasis and temperature is lacking (Tabarean et al. 2009 ).
It has also been shown that stimulation of the adenosine A 1 receptor (A 1 AR) within the hypothalamus decreases T b . Although there are many studies showing that A 1 ARs play a role in thermoregulation (Steiner et al. 2002; Swoap et al. 2007; Tamura et al. 2005) , there are no studies to our knowledge that have linked alterations in purinergic signaling to DR-induced cooling.
In this study, we test the hypothesis that DR imposed by every-other-day feeding (EODF) lowers T b by sensitizing the response to A 1 AR stimulation. Moreover, we test the hypothesis that sensitization is associated with increased A 1 AR surface expression within the hypothalamus. Sensitization to cooling effects of A 1 AR stimulation via increased A 1 AR surface expression may account for the chronic decrease in T b following DR and contribute to increased longevity in DR animals.
Materials and methods
Experimental animals All procedures were approved by UAF's Animal Care and Use Committee. Male SpragueDawley rats (90 days old; Simonson Laboratories, Gilroy, CA, USA) were housed two per cage at an ambient temperature of 20°C, on 12:12 L:D, and fed either ad libitum (AL) or a dietary-restricted diet. IPTT-300 transponders (BioMedic, Seaford, DE, USA) used to monitor T b were implanted on day 1. DR was started on day 2. Dietary-restricted animals were fed every other day (AL for 24 h periods), and food was removed on alternate days. Body temperature (T b ) and respiratory rate (RR), monitored by visual inspection, were monitored daily between 11:00 a.m. and 1:00 p.m. just prior to feeding if food was added. Body weight was measured every fourth day after collecting T b and RR. Drug was delivered on day 29 after 27 days of DR. On day 29, five animals from each dietary group were injected intraperitoneal with either N 6 -cyclohexyladenosine (CHA; 0.5 or 5.0 mg/kg; SigmaAldrich, St. Louis, MO, USA) or vehicle (0.01 M phosphate buffer pH 7.0 for 0.5 mg/kg and DMSO, 1% for 5.0 mg/kg). T b and RR were monitored every 30 min commencing just prior to drug injection and for 4 h after drug injection. T b and RR were recorded again 24 h after drug injection. DR was continued for 48 h after drug testing. Animals were anesthetized with isoflurane, and brain tissue was rapidly dissected and frozen in liquid nitrogen then stored at −80°C until use.
Cell fractionation for western blot In order to insure that changes in receptor levels were not influenced by the introduction of CHA, only tissue from DR and AL animals treated with vehicle were used in the western blot experiments. Approximately 30 μg of frontal cortex or whole hypothalamus were homogenized and fractionated as described previously (Raval et al. 2003) . Briefly, tissue was suspended in ten times volume of freshly made ice-cold homogenization buffer [4 mM ATP, 100 mM KCl, 10 mM imidazole, 2 mM EGTA, 1 mM MgCl 2 , 20% glycerol, 17 μg/mL (1 mM) PMSF, 20 μg/mL soybean trypsin inhibitor, 25 μg/mL leupeptin, and 25 μg/mL aprotinin] with 0.05% Triton X-100. The suspended tissue was homogenized in an all-glass homogenizer (ten to 15 strokes) then centrifuged (1,000×g, 4°C) for 10 min. The resulting supernatant (soluble and cytosolic fraction) was removed and centrifuged at 16,000×g and 4°C for 15 min and stored at −80°C until use. The initial pellet (particulate and membrane fraction) was re-suspended in 250 μL of the same lysis buffer containing 1% Triton X-100 and extracted on ice for 60 min. The extracted membrane fraction was then centrifuged (16,000×g, 4°C) for 15 min to remove debris and stored at −80°C until use.
Western blot Protein concentration was determined using the Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, USA). Twenty-five micrograms of protein was separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, transferred to nitrocellulose membrane, and blocked with 5% milk in Tris-buffered saline (TBS; 10 mM Tris-HCl, pH 7.5, and 150 mM NaCl) for 1 h at room temperature with gentle agitation. Membranes were then incubated overnight with rabbit anti-A 1 AR (1:1,000, Cat#PC158, Calbiochem, San Diego, CA, USA) in TBST+ 5% milk overnight at 4°C with gentle agitation. The membrane was washed three times over 30 min in 5% milk-TBST (TBS and 0.1% Tween 20) at room temperature with gentle agitation, then incubated in secondary antibody (Goat anti-rabbit, 1:10,000, Santa Cruz Biotechnology) for 1 h at room temperature. The bands were visualized with enhanced chemiluminescence (Supersignal West Pico Substrate, Pierce, Rockford, IL, USA) then digitally imaged using an AutoImager 3400 (Alpha Innotech Corporation, San Leandro, CA, USA). The membrane was then stripped by incubation with TBS (pH 2.0; 10 mM Tris-HCl and 150 mM NaCl) for 30 min and re-probed with rabbit anti-Na + /K + ATPase β-1 (1:5,000, Cat#06-170 Upstate, Lake Placid, NY, USA) to assess the purity of the membrane fractions. After visualization, the membrane was stripped and re-probed in the same manner with mouse anti-β-actin (1:5,000 product# A5316, Sigma) as a loading control using Goat anti-mouse HRP (1:10,000, Bio-Rad) as the secondary antibody.
Data analysis Digitized images of chemiluminescent bands were analyzed using ImageQuant 5.2. Total A 1 AR content was calculated as the summed densities of the cytosolic and membrane fractions and normalized as a percent of the mean of the control (AL) group on each gel. Surface expression of A 1 AR was assessed from the ratio of density of the particulate A 1 AR bands to the density of the cytosolic A 1 AR bands.
Statistics To assess the effect of diet on T b and RR, data was analyzed by analysis of variance (ANOVA) with repeated measures over time followed by two-way ANOVAs and Tukey post hoc comparisons (SAS, v. 9.1). Baseline T b and RR prior to drug treatment are shown and were analyzed as raw data. T b and RR after CHA or vehicle injection is shown as raw data but was analyzed as percent of pre-injection values to normalize for differences in T b and RR between DR and AL groups at the time of drug injection. Data are shown as mean±SEM. Densities of immunoreactive bands were expressed as the ratio of cytosolic to membrane fractions normalized to the average of the AL group for each blot. Western blot results for DR and AL groups were compared by t tests (Excel, v. 2007) .
Results
Body weight, monitored every 4 days until the day of injection, increased in both DR and AL-fed rats until the day of injection (p<0.0001, n=20, main effect of time). By the day of injection, however, DR rats weighed significantly less than the AL rats (p<0.0001, diet×time; p<0.05, n=10,10, DR vs. AL on day 29, Tukey test; Fig. 1 ). No difference was noted in weight gain between groups of DR and AL-fed animals that were subsequently tested with CHA or vehicle.
Dietary restriction decreases resting body temperature and respiratory rate As expected, DR decreased resting T b and RR. Three-way ANOVAs showed main effects of diet on T b (p<0.0001) and RR (p<0.001). Interestingly, the diet-induced decrease in resting RR occurred 2 days prior to the diet-induced decrease in resting T b . RR was consistently different between groups beginning on day 20 (p<0.05 Tukey tests; Fig. 2c ). By contrast, resting T b was consistently different between dietary groups beginning on day 22 through to the day of drug testing (p<0.05 Tukey tests; Fig. 2a ).
Dietary restriction sensitizes rats to the effects of CHA on body temperature and respiratory rate The A 1 AR agonist CHA produced a significant decrease in T b in both AL and DR groups ( Fig. 2b ; p<0.0001, n=5,5, diet×drug×time for three-way ANOVA; p<0.0001 drug× time in AL group; and p<0.0001 drug×time in DR group in subsequent two-way ANOVAs). Post hoc analysis showed that in animals fed AL, CHA induced a decrease in T b that was different from vehicle-treated animals between 0.5 and 2.5 h after drug injection (p<0.05 CHA vs vehicle at 0.5 to 2.5 h, Tukey test). In animals fed a restricted diet, CHA induced a decrease in T b that was different from vehicle-treated animals between 0.5 and 3.5 h after drug injection (p<0.05 CHA vs vehicle at 0.5 to 3.5 h Tukey test).
The effect of CHA on T b was greater in DR rats than in AL rats (p<0.0001, n=5,5 diet×time where DR animals treated with CHA were compared to AL animals treated with CHA, and vehicle-treated animals were not included in the two-way ANOVA). Post hoc comparisons showed a difference between AL and DR groups treated with CHA at 0.5 to 3.5 h after drug injection; p<0.05 Tukey tests, Fig. 1b ). These results demonstrate that prolonged DR sensitizes rats to the cooling effects of CHA.
In addition to decreasing T b , CHA also induced a significant decrease in RR in both dietary groups ( Fig. 1d ; p<0.05, n=5,5, diet×drug×time for three-way ANOVA; p<0.01 drug×time in AL group; and p<0.0001 drug×time in DR group in subsequent two-way ANOVAs). Post hoc analysis showed that in animals fed AL, CHA induced a decrease in RR that was different from vehicle-treated animals between 1.0 and 1.5 h after drug injection (p<0.05 CHA vs vehicle at 1.0 to 1.5 h, Tukey test). Likewise, in animals fed a restricted diet, CHA induced a decrease in RR that was different from vehicle-treated animals between 0.5 and 3.5 h after drug injection (p<0.05 CHA vs vehicle at 0.5 to 3.5 h, Tukey test). These data suggested that the effects of CHA on RR were enhanced in DR animals.
DR-induced decrease in T b is thought to enhance longevity, in part, by decreasing metabolism. RR declines with metabolic rate in studies of metabolic suppression during onset of torpor (Elvert and Heldmaier 2005) and is thus an indirect indicator of metabolic suppression. We therefore asked if DR sensitized animals to the effects of CHA on RR. The CHA-induced decrease in RR was indeed greater in the DR group than in the AL group out to 3.5 h after drug administration (Fig. 2d) . This was evident from a two-way ANOVA comparing the effects of CHA in DR and AL-fed animals that excluded vehicle-treated animals (p < 0.0001, n = 5,5 diet × time). Post hoc comparisons showed a difference between AL and DR groups treated with CHA between 0.5 and 3.5 h after drug injection (p<0.05 Tukey tests). These results demonstrate that prolonged DR sensitizes rats to the effects of CHA on RR.
Contrary to expectations that metabolic suppression results from a reduction in T b , we found that a decrease in RR preceded the decline in T b . This was true for resting RR during 27 days of DR and for CHA-induced decreases in RR. In support of this interpretation, a one-way ANOVA with repeated measures over time showed that in DR animals, RR reached a minimum within 0.5 h after CHA, while T b continued to decline for 2 h after CHA (p<0.05, Tukey test). Similarly, the small decrease in T b in the AL fed rats was preceded by a decrease in RR. In the AL group, a one-way ANOVA showed that RR reached a minimum at 1 and 1.5 h after CHA. By contrast, T b did not reach a minimum until 2 h after CHA.
Effects of the higher 5 mg/kg dose of CHA were compromised by side effects and subsequent death. All ten animals were administered this dose in one test session, and subsequent use of this high dose was abandoned.
Dietary restriction increases surface expression of A 1 AR in hypothalamus
We next asked if surface expression of A 1 AR increased in DR animals as a potential mechanism of sensitization. The relative concentrations of A 1 AR were determined in the cytosolic and membrane fractions of vehicle-treated AL or DR rat cortex and hypothalamus by western blot. In cortex, the relative density of total A 1 AR protein, calculated from the sum of band densities in the cytosolic and membrane fractions, was not different between the DR and AL animals (p>0.05, n=9,10, t test). Similarly, the relative proportion of A 1 AR in the cytosolic and membrane fractions was not different between the AL and DR groups (p>0.05, n=9,10, t test). When the total expression of A 1 AR was determined in hypothalamus, again by summing density of bands in the cytosolic and membrane fractions, there was no significant difference between the AL and DR animals (p>0.05, n=8,10, t test). However, the ratio of densities of A 1 AR in cytosolic and membrane fractions of the AL animals was significantly different than the ratio in DR animals (p<0.05, n=8,10, t test, Fig. 3 ). This shift in the relative densities of the A 1 AR from the cytosol to the membrane suggests that A 1 AR are mobilized from a nonfunctional cytosolic pool to a functional surface pool.
We next asked if the effect of DR on A 1 AR surface expression or CHA-induced lowering of body temperature depended on a change in food intake or body weight. In the DR group, all five animals tested gained less weight than the AL-fed animals. The body weight gain in the DR group ranged from 7 to 14 g, and the drug-induced decrease in body temperature in this group ranged from 6.6°C to 7.1°C. The body weight gain in the AL group ranged from 15 to 44 g, and the drug-induced decrease in body temperature ranged from 2.4°C to 2.8°C, (n=5 per group). These results show that despite a variable weight gain in the AL-fed animals, weight gain had little influence on drug-induced lowering of body temperature. The small range of body weight gain and drug-induced change in body temperature in the DR animals made it difficult to assess how weight gain influenced other dependent variables. 
Discussion
Here, we show for the first time that DR-induced modification of thermoregulation is associated with changes in components of the purinergic neuromodulatory system. DR imposed by EODF sensitizes rats to the cooling and metabolic depressant effects of CHA, an A 1 AR agonist. We also report that DR is associated with altered surface expression of A 1 AR in hypothalamus, but not cortex. Taken together, these data suggest that DR sensitizes A 1 AR through an increase in surface expression in thermoregulatory regions of the hypothalamus and in this way contributes to the decline in T b and RR in animals subjected to DR.
Here, we used a well-characterized paradigm of DR, described in the literature as EODF or intermittent fasting, to test the hypothesis that a decrease in T b is associated with sensitization to the cooling effects of an A 1 AR agonist. The EODF paradigm, like other DR paradigms, decreases T b (Fraifeld and Kaplanski 1997) typically within 4 weeks of onset (Wan et al. 2004 ) and increases longevity (Goodrick et al. 1983) . Effects of EODF on T b (Fraifeld and Kaplanski 1997) are similar to the effects observed with several other paradigms of DR that are associated with increased longevity (Goodrick et al. 1983 ) and decreased metabolism (McCarter and McGee 1989; McCarter and Palmer 1992; Valle et al. 2005) .
The amount of food consumed by rodents fed every other day varies with strain. Food intake has been reported to be 30% less than rats fed AL (Wan et al. 2004 ). However, in C57BL/6 mice, increased food intake on feeding days offsets absence of food intake on fasting days such that overall intake is not decreased (Anson et al. 2003) . Individual food intake was not monitored in the present study to avoid the potential effects of stress associated with individual housing. Body weight gain in rats fed every other day in the present study differed only slightly from rats fed AL, suggesting that food intake was decreased but was not dramatically different from AL-fed rats.
When compared with 40% caloric restriction, EODF produces slightly different decreases in heart rate, blood pressure, and blood glucose (Mager et al. 2006) . It remains to be determined if all DR paradigms enhance the cooling effects of CHA and if sensitization of A 1 AR is a common mechanism for altering thermoregulation in all DR paradigms or if a decrease in food intake is necessary for the observed effect. Stress and other aspects of EODF that are not related to decreased food intake may contribute to lowered resting T b and sensitization to CHA.
A negative energy balance could compromise thermogenic capacity and contribute to lower resting T b . Others (Fraifeld and Kaplanski 1997) show that lipopolysaccharide induces similar maximal T b in rats fed every other day suggesting that in their study, thermogenic capacity was not compromised. Compromised thermogenic capacity due to a negative energy balance is unlikely since body weight gain in DR rats differed so slightly from AL-fed animals.
Restricted feeding schedules, which limit food availability to a single meal each day, induce and entrain circadian rhythms in food-anticipatory activities in rodents (Verwey and Amir 2009) . Animals in the DR group of rats may have entrained to feeding which occurred at the same time every other day. Anticipation of food on feeding days would have been expected to increase activity and T b for 2 to 3 h prior to feeding in the DR group (Fuller et al. 2008 ). Since T b and RR were measured just before feeding, food entrainment would have increased T b and RR in the DR group, but not in the AL-fed animals. While a food entrainment-induced increase on T b and RR in the DR group can not be ruled out, it was not sufficient to override a significant decrease in resting T b and RR in this group of animals. Similarly, since RR and T b were monitored during the middle of the light period, activity and resting T b should have been at a minimum in AL animals. This assumed minimum in RR and T b in the AL-fed animals was still higher than resting RR and T b in the DR animals. Thus, while food entrainment Fig. 3 Blot (a) demonstrates fraction purity using Na + /K + ATPase as a marker for the membrane fraction. Blot (b) shows one representative blot of hypothalamus where density of A 1 AR bands in the cytosolic fractions is decreased and density of A 1 AR bands in the membrane fractions is increased in rats fed every other day. Graph in (c) shows that normalized ratios of membrane to cytosolic band densities in hypothalamus from rats fed a restricted diet are significantly higher than for rats fed ad libitum (asterisk p<0.05, n=5 per group) in the DR animals and circadian rhythms in the AL animals may have influenced RR and T b , it is unlikely that the observed differences between these two groups in resting values or CHA-induced decreases in T b or RR are artifacts of these influences.
In the present study, DR induced a decrease in resting RR, an indicator of oxidative metabolism prior to a decrease in resting T b . Moreover, the CHA-induced decrease in RR occurred prior to the CHA-induced decrease in T b . A decrease in respiration that precedes a decrease in T b mimics what is observed in hibernating animals during entrance into torpor (Drew et al. 2007; Elvert and Heldmaier 2005; Karpovich et al. 2009 ) and suggests that inhibition of metabolism precedes the decline in T b rather than vice-versa as is often suggested for DR (Conti 2008) .
During onset of torpor, the decline of metabolism, heart rate, and RR occur in parallel and before a decline in T b (Elvert and Heldmaier 2005) . Thus, in studies of metabolic suppression, RR and heart rate serve as indirect indicators of metabolic suppression. In the present study, a decrease in RR is interpreted as a decrease in metabolism. This interpretation is made with the caveat that direct effects of adenosine or CHA on respiratory control centers or stress-induced sympathetic responses could influence RR independent of effects on metabolism. Stress-induced effects on resting RR are unlikely since rats were observed daily and would have been expected to habituate to the observer. It is more difficult, however, to discount direct effects on respiratory control centers.
Adenosine plays a neuromodulatory role in thermoregulation (Barros et al. 2006) . Recent evidence supports an emerging role for A 1 AR signaling in thermoregulatory alterations during onset of torpor in hibernating animals as well as in daily torpor in mice (Swoap et al. 2007 ). Because CHA-induced cooling in DR rats qualitatively resembled torpor in hibernating animals where metabolic suppression precedes a gradual decline in T b , we asked if a maximal dose of CHA would induce torpor and drive T b closer to ambient temperature. The high (5.0 mg/kg) dose of CHA proved to be lethal in AL and DR rats. This was unexpected because previous studies showed that 3 mg/kg was well tolerated in rats (Tuovinen and Tarhanen 2004) , and 5 mg/kg produced sedation and cooling in mice (Assi 2001) . Further deaths were avoided by immediately abandoning use of this dose as soon as side effects and death were noted in the first group of animals tested.
Because sensitization is defined by an altered doseresponse curve, we asked if a maximally effective dose of CHA in AL-fed rats would produce an effect similar to a lower dose of CHA in DR rats. Indeed, we tested a higher dose of CHA expecting to see results consistent with a shift in the dose-response curve; however, the higher dose proved lethal in both dietary groups. Inverted U-shaped dose-response curves can cause decreased responsiveness to appear as sensitization when a single dose is tested. Because drug-induced hypothermic effects can follow inverted dose-response curves (Jaszberenyi et al. 2002) , the possibility exists that enhanced responsiveness to CHA is due to a rightward shift in the dose-response relationship and not sensitization. Nonetheless, we interpret the current results as evidence for increased responsiveness to CHA because (1) our hypothesis predicted that DR animals would show an increased response to CHA, (2) a decrease in resting T b supports increased sensitivity to endogenous adenosine, and (3) increased surface expression of A 1 AR is consistent with sensitization.
A 1 AR agonists inhibit lipolysis via direct effects on adipocytes in white and brown adipose tissue (WAT and BAT; Viswanadha and Londos 2006) . Inhibition of lipolysis in BAT inhibits nonshivering thermogenesis (Asakura 2004) and, therefore, the oxidative metabolism associated with this energy demanding process. Although we suggest that CHA suppresses RR and T b via effects on central thermoregulatory pathways, we can not rule out a peripheral site of action. Sensitization of A 1 AR in BAT would increase endogenous adenosine-or CHA-induced inhibition of nonshivering thermogenesis and oxygen consumption and be expected to produce an immediate decline in RR and a subsequent more gradual decrease in T b .
If glycogen reserves are depleted in DR animals, direct inhibition of lipolysis in WAT could limit fuel availability and impair thermogenesis. Data reported here argues against this interpretation, however, because RR and T b in the DR group of animals did not vary between days following 24 h fasts and days following 24 h food availability.
Receptor sensitization suggested by the present results may be a common means to modulate purinergic signaling. Sleep deprivation increases adenosine receptor surface expression, which may contribute to sleep drive in humans (Elmenhorst et al. 2007 ). Although we did not detect a change in total A 1 AR expression, studies involving transgenic mice indicate that receptor levels limit response to endogenous adenosine as most effects studied were amplified upon increases in receptor level (Yaar et al. 2005) . Results suggest that sensitization may result from a change in the distribution of A 1 AR from the cytosol to the membrane. A 1 AR interactions with other membrane receptors, enzymes, adaptor and scaffolding proteins, as well as dimerization of A 1 AR within the membrane play a role in receptor trafficking, internalization, and desensitization (Franco et al. 2005) . Knowledge of these mechanisms opens the possibility for further investigation into mechanisms of A 1 AR sensitization following DR. Moreover, an effect of DR on extracellular levels of adenosine may also play a role in the observed effect. A change in surface expression does not rule out an influence of presynaptic mechanisms where adenosine kinase plays a primary role in regulating extracellular levels of adenosine (Li et al. 2007) .
Adenosine is neuroprotective in a variety of brain injury models via multiple mechanisms including a decrease in T b (Bischofberger et al. 1997; Xu et al. 2006 ). The present results suggest that diet may be a means to sensitized A 1 AR responsiveness and in this way facilitate therapeutic effects of endogenous or exogenously applied adenosine. Ketogenic diets, like adenosine, protect the brain from several types of injuries (Prins 2008) and decrease incidence of seizure in intractable epilepsy potentially via purinergic mechanisms (Etherington et al. 2009; Masino and Geiger 2009) . EODF leads to intermittent periods of ketosis (Anson et al. 2003) , but unlike EODF, ketogenic diets have not been shown to decrease T b or increase life span.
In summary, we show that DR sensitizes rats to the respiratory depressant and cooling effects of an A 1 AR agonist. Sensitization of thermoregulatory effects of endogenous adenosine through increased surface expression of A 1 AR may play a role in lowered body temperature and enhanced longevity associated with DR. Evidence that diet can modulate purinergic signaling has implications for the treatment of brain injury, stroke, epilepsy, and aging.
